> Retour à la liste des séminaires


Du Jeudi 24 Octobre 2019 Au Vendredi 25 Octobre 2019
De 8h30 à 19h
Centre de recherche - Paris - Amphithéâtre Constant-Burg - 12 rue Lhomond, Paris 5e

Symposium tribute to Maxime DAHAN

Robert H. Singer
Robert H. Singer waw awarded the Maxime Dahan Prize for Innovation in Methods and Instrumentation at the Interface of Physics, Biology & Medicine.
More information in "En bref / In short".

This 2-day symposium is a tribute to the life, career and research of Maxime DAHAN, director of the physical-chemistry unit (UMR 168) of the Curie Institute between 2013 and 2018, and group leader of the “Light based observation and control of cellular organization” research group. After a brilliant academic career at L’Ecole Polytechnique and L’Ecole normale supérieure (ENS), Maxime spent 12 years in the ENS Kastler Brossel laboratory. As an attestation to his high level of scientific excellence, the CNRS awarded him a bronze medal in 2006. He then continued his research at the Janelia Farm Research Center outside Washington D.C. for two years before joining Institut Curie.

Upon joining Institut Curie as director of the Physico-Chemistry unit in January 2013, Maxime immediately became very active in the both the broader organization of the Institut Curie and the daily research and life of the Institute. Notably, Maxime laid the groundwork for an interaction between physics and clinical practice that provided a new perspective on cancer as well as innovative treatments. Beyond being a main scientific player on the national and international level in the domain of biophysics and single molecule imaging, Maxime always pushed mentorship, collaboration and innovation as demonstrated by his dedication to teaching, his involvement in several innovative start-up companies and his leading roles in the Labex Celtisphybio, the European FETopen Magneuron project and the Q-Life Institute.

This symposium in his memory gathers several world-renowned scientists in the field of Biophysics with whom Maxime collaborated over his scientific career to talk both about their research in addition to personal stories and memories of Maxime.

Affiche du séminaire

En bref

The Maxime Dahan Prize for Innovation in Methods and Instrumentation at the Interface of Physics, Biology & Medicine.

The prize will be overseen by an internationally recognized scientific advisory committee and delivered at a major scientific conference.



Robert H. Singer received an undergraduate degree in physical chemistry from Oberlin College, and a PhD in developmental biology from Brandeis University. He did postdoctoral work in molecular biology at the Massachusetts Institute of Technology and the Weizmann Institute of Science in Rehovot, Israel. Oberlin College granted Singer an Honorary Doctor of Science in 2016. The Hebrew University of Jerusalem granted Singer an Honorary Doctorate in 2018.
He holds the following positions at the Albert Einstein College of Medicine, New York: Professor and Co-Chair, Department of Anatomy and Structural Biology; Professor, Dominick P. Purpura Department of Neuroscience; Professor, Department of Cell Biology; Co-Director, Integrated Imaging Facility; and Co-Director, Gruss Lipper Biophotonics Center. Singer is a senior fellow at the Janelia Research Campus of the Howard Hughes Medical Institute in Virginia.

His career has been focused on the cell biology of RNA, the molecule responsible for making all the proteins in the cell, it converts the instructions from the gene into reality. A patented technique his lab developed for detecting single RNA in cells revealed that the RNA can be directed to specific cellular compartments. This work has given rise to a new field of RNA transport and localization, enhanced by development of imaging technology and modified RNA molecules. His lab has shown how RNA is made from a gene in a live cell.

His laboratories at Einstein and Janelia have been instrumental in developing rapid and sensitive microscopy that can study single molecules of RNA in living cells and in animals, and in devising methods to track them through their life cycle. This technology has led to understanding the role of RNA in such disease processes as cancer metastasis and intellectual disability. He holds 12 patents on his work, and has founded several biotech companies and sits on the board of and consults with several more.
For his works, he was elected to the US National Academy of Sciences, American Academy of Arts and Sciences, and the American Association for the Advancement of Science.

En savoir plus

Register before September 30, 2019 - it is free but space is limited (200 places)


Our partner INCEPTION Institut Pasteur